Dr. Christensen is recognized worldwide as an expert in
learning technology. He has pioneered adaptive learning, data-driven content
development, simulation and debriefing technologies. He is responsible for the
strategy of Area9 Group’s businesses, which span from purpose-built platforms
for optimization of business processes for large corporations over digital
product design to corporate training based on intelligent, adaptive learning. Founded
his first company, Sophus Medical, in 1997 while still in medical school.
Sophus Medical was acquired by Laerdal Medical in 2002.
Dr. Christensen co-founded Area9 Group in 2006, which has
been at the forefront of adaptive and personalized learning. Area9 Education
was sold to McGraw-Hill Education in 2014. Area9 Learning was then established
to focus on adaptive learning in corporate and organizational environments. Dr.
Christensen was part of the McGraw-Hill Higher Education leadership team from
2011 to 2014 and the Executive Leadership Team from 2014 to 2016.
Today, his primary focus is Area9 Lyceum which in January
2018 assembled all the group’s educational investments and technologies, and
set out to create the 4th generation adaptive learning platform and the first
generation supporting four dimensional education. In addition, he is the
chairman of Altus Care and in 2017, Dr. Christensen was appointed
expert-in-residence at the translational accelerator at Brigham and Women’s
Hospital-Harvard Medical School. He is on the boards of LEAP Innovation,
Mastery Transcript Consortium, as well as, the advisory board for Transcend
Education, CharacterLab, Center for Curriculum Redesign at Harvard University
and is also the co-chair of the advisory board in emergency medicine at Brigham
and Women’s hospital in Boston.